Clinical Drug Supply Chain Services Market Report 2026

Clinical Drug Supply Chain Services Market Overview

• Clinical Drug Supply Chain Services market size has reached to $8.13 billion in 2025 • Expected to grow to $13.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Number Of Clinical Trials Driving The Growth Of The Market Due To Increasing Drug Development Activities And Regulatory Approvals • Market Trend: Improving Reliability In Drug Distribution Through Advanced Cold Chain Networks • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clinical Drug Supply Chain Services Market?

Clinical drug supply chain services involve managing the sourcing, packaging, storage, distribution, and tracking of investigational drugs throughout clinical trials. Their purpose is to ensure timely, compliant, and condition-controlled delivery of trial materials, maintaining study integrity and patient safety. The main types of clinical drug supply chain services include cold chain logistics, serialization and track trace, and specialized clinical packaging. Cold chain logistics refers to temperature-controlled transportation and storage solutions used to maintain the stability, safety, and efficacy of clinical trial drugs throughout the supply chain. These services are structured for drug types such as small molecule, biologics products, cell therapy, and other drug types. The various applications involved are clinical trial drug distribution, temperature controlled drug shipping, regulatory compliant labeling, and return and destruction services, and they are used by several end users such as pharmaceutical companies, biotechnology companies, and contract research organizations.

What Is The Clinical Drug Supply Chain Services Market Growth Forecast?

The clinical drug supply chain services market size is expected to see rapid growth in the next few years.It will grow to $13.12 billion by 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to ai-enabled predictive supply chain optimization, expansion of decentralized and hybrid clinical trials, rising adoption of real-time supply chain monitoring, growth in personalized medicine and cell and gene therapy trials, increasing automation in clinical logistics operations.Major trends in the forecast period include cold chain optimization for clinical trial logistics, decentralized clinical trial drug distribution models, real-time shipment visibility and tracking in global trials, increased outsourcing to clinical supply specialists, demand for patient-centric investigational drug delivery models.

Global Clinical Drug Supply Chain Services Market Segmentation

1) By Type: Cold Chain Logistics, Serialization And Track Trace, Specialized Clinical Packaging 2) By Drug Type: Small Molecule, Biologics Products, Cell Therapy, Other Drug Types 3) By Application: Clinical Trial Drug Distribution, Temperature Controlled Drug Shipping, Regulatory Compliant Labeling, Return And Destruction Services 4) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations Subsegments: 1) By Cold Chain Logistics: Temperature Controlled Storage Services, Refrigerated Transportation Services, Frozen Drug Distribution Services, Real-Time Temperature Monitoring Solutions, Cryogenic Shipping Services 2) By Serialization And Track Trace: Unique Product Identifier Management, Aggregation And Deaggregation Services, Regulatory Compliance Reporting, Real-Time Track And Trace Software, Anti-Counterfeiting Verification Solutions 3) By Specialized Clinical Packaging: Blister Packaging Services, Bottle And Vial Packaging Services, Unit Dose Packaging Solutions, Customized Clinical Trial Kits, Tamper-Evident Packaging Solutions

What Is The Driver Of The Clinical Drug Supply Chain Services Market?

The increasing number of clinical trials is expected to propel the growth of the clinical drug supply chain services industry going forward.Clinical trials refer to structured research studies conducted on human participants to evaluate the safety, efficacy, and dosage of new drugs and medical treatments.The rise in clinical trials is driven mainly by increasing drug development activities and regulatory approvals in developed healthcare systems.Clinical drug supply chain services help this by managing drug manufacturing, packaging, storage, and distribution to ensure timely and compliant delivery of investigational products across trial sites.For instance, in December 2024, according to the National Library of Medicine (ClinicalTrials.gov), a US-based government clinical trial registry, the number of registered clinical studies increased from approximately 479,859 studies in January 2024 to over 570,636 studies by December 2024.Therefore, the increasing number of clinical trials is driving the growth of the clinical drug supply chain services industry.

Key Players In The Global Clinical Drug Supply Chain Services Market

Major companies operating in the clinical drug supply chain services market are United Parcel Service Inc., DHL International GmbH, FedEx Corporation, Thermo Fisher Scientific Inc., Kuehne + Nagel International AG, IQVIA Holdings Inc., Yusen Logistics Co. Ltd., ICON Public Limited Company, Lonza Group AG, Catalent Inc., Parexel International Corporation, PCI Services LLC, Almac Group Limited, World Courier Management Inc., Marken Limited, Piramal Pharma Limited, Movianto International GmbH, Clinigen Group plc, Sharp Clinical Services Inc., Biocair International Limited, Ancillare LP, Bilcare Limited, Myonex Inc.

Global Clinical Drug Supply Chain Services Market Trends and Insights

Major companies operating in the clinical drug supply chain services market are focusing on expanding cold chain freight forwarding capabilities, such as state‑of‑the‑art temperature‑controlled cross‑dock and logistics networks to maintain precise conditions for sensitive pharmaceutical products throughout transit. These capabilities combine strategically located global facilities with integrated monitoring and certification systems to ensure quality and compliance for clinical drug shipments. For instance, in August 2025, UPS Healthcare, a US‑based logistics and supply chain services provider, expanded its global cold chain freight forwarding network with 20 advanced cross‑dock facilities in key cities including Chicago, Singapore, Amsterdam, and Shanghai, featuring refrigerated and controlled room temperature handling, inbound/outbound consolidation with thermal blankets and dry ice support, and multiple certifications such as GDP and IATA CEIV Pharma to enhance package integrity. While regional infrastructure requirements and operational costs remain considerations, these enhancements significantly strengthen precision handling and delivery reliability for clinical drug supply chains worldwide.

What Are Latest Mergers And Acquisitions In The Clinical Drug Supply Chain Services Market?

In March 2025, DHL Group, a Germany-based logistics and supply chain provider, acquired CRYOPDP for an undisclosed amount. Through this acquisition, DHL aims to strengthen its specialty pharma logistics capabilities, expand its clinical trial supply chain services, and enhance its global position in handling temperature-sensitive and time-critical shipments for biopharmaceutical and clinical research applications. CRYOPDP is a US-based specialty courier company focused on clinical trials, biopharma logistics, and cell and gene therapy supply chain solutions.

Regional Insights

North America was the largest region in the clinical drug supply chain services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Drug Supply Chain Services Market?

The clinical drug supply chain services market consists of revenues earned by entities by providing services such as planning, sourcing, labeling, storage, and distribution of clinical trial drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

What is the Market Assessment and Strategic Outlook for the Clinical Drug Supply Chain Services Industry?

The clinical drug supply chain services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical drug supply chain services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Clinical Drug Supply Chain Services Market Report 2026?

The clinical drug supply chain services market research report is one of a series of new reports from The Business Research Company that provides clinical drug supply chain services market statistics, including clinical drug supply chain services industry global market size, regional shares, competitors with a clinical drug supply chain services market share, detailed clinical drug supply chain services market segments, market trends and opportunities, and any further data you may need to thrive in the clinical drug supply chain services industry. This clinical drug supply chain services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.